Page last updated: 2024-11-03

ono 1078 and Airflow Obstruction, Chronic

ono 1078 has been researched along with Airflow Obstruction, Chronic in 2 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Research Excerpts

ExcerptRelevanceReference
"New drugs and new approaches of the treatment of chronic obstructive pulmonary disease (COPD) are needed."2.45Targeting leukotrienes for the treatment of COPD? ( Drakatos, P; Karkoulias, K; Lykouras, D; Sampsonas, F; Spiropoulos, K, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohbayashi, H1
Shibata, N1
Hirose, T1
Adachi, M1
Drakatos, P1
Lykouras, D1
Sampsonas, F1
Karkoulias, K1
Spiropoulos, K1

Reviews

1 review available for ono 1078 and Airflow Obstruction, Chronic

ArticleYear
Targeting leukotrienes for the treatment of COPD?
    Inflammation & allergy drug targets, 2009, Volume: 8, Issue:4

    Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Arachidonate 5-Lipoxygenase; Bronchoconstriction; Capi

2009

Trials

1 trial available for ono 1078 and Airflow Obstruction, Chronic

ArticleYear
Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study.
    Pulmonary pharmacology & therapeutics, 2009, Volume: 22, Issue:6

    Topics: Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Bronchodilator Age

2009